Gamal Akabani

4.3k total citations · 1 hit paper
67 papers, 3.1k citations indexed

About

Gamal Akabani is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, Gamal Akabani has authored 67 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Radiology, Nuclear Medicine and Imaging, 21 papers in Pulmonary and Respiratory Medicine and 17 papers in Radiation. Recurrent topics in Gamal Akabani's work include Radiopharmaceutical Chemistry and Applications (39 papers), Medical Imaging Techniques and Applications (28 papers) and Advanced Radiotherapy Techniques (12 papers). Gamal Akabani is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (39 papers), Medical Imaging Techniques and Applications (28 papers) and Advanced Radiotherapy Techniques (12 papers). Gamal Akabani collaborates with scholars based in United States, South Korea and Australia. Gamal Akabani's co-authors include Michael R. Zalutsky, Darell D. Bigner, Roger E. McLendon, Allan H. Friedman, Henry S. Friedman, R. Edward Coleman, Terence Z. Wong, David A. Reardon, H. Kim Lyerly and Rob Coleman and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Gamal Akabani

66 papers receiving 3.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

MIRD Pamphlet No. 22 (Abridged): Radiobiology and Dosimetry of α-Particle Emitters for Targeted Radionuclide Therapy

2010 384 citations Gamal Akabani et al. Journal of Nuclear Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gamal Akabani United States	29	1.9k	726	669	533	481	67	3.1k
Shin‐Ichi Miyatake Japan	39	1.6k 0.8×	832 1.1×	678 1.0×	974 1.8×	528 1.1×	165	4.4k
Stewart Kroll United States	29	1.8k 0.9×	945 1.3×	1.3k 1.9×	596 1.1×	281 0.6×	71	4.0k
Kayhan Garmestani United States	36	2.4k 1.3×	754 1.0×	815 1.2×	424 0.8×	216 0.4×	68	3.1k
Kei Nakai Japan	29	978 0.5×	420 0.6×	221 0.3×	255 0.5×	273 0.6×	177	2.9k
J.C. Grecula United States	31	710 0.4×	1.0k 1.4×	978 1.5×	430 0.8×	130 0.3×	159	2.8k
Åse Ballangrud United States	27	1.2k 0.7×	1.2k 1.7×	603 0.9×	363 0.7×	104 0.2×	59	2.6k
Reingard Senekowitsch–Schmidtke Germany	31	2.3k 1.2×	629 0.9×	826 1.2×	1.2k 2.3×	139 0.3×	84	3.9k
Jörgen Carlsson Sweden	40	2.9k 1.6×	711 1.0×	1.6k 2.4×	1.4k 2.7×	180 0.4×	126	4.7k
Laurence Desjardins France	39	898 0.5×	869 1.2×	1.7k 2.5×	1.3k 2.5×	438 0.9×	188	5.0k
Florian Gaertner Germany	32	1.3k 0.7×	929 1.3×	644 1.0×	494 0.9×	417 0.9×	85	2.9k

Countries citing papers authored by Gamal Akabani

Since Specialization

Citations

This map shows the geographic impact of Gamal Akabani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal Akabani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal Akabani more than expected).

Fields of papers citing papers by Gamal Akabani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gamal Akabani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal Akabani. The network helps show where Gamal Akabani may publish in the future.

Co-authorship network of co-authors of Gamal Akabani

This figure shows the co-authorship network connecting the top 25 collaborators of Gamal Akabani. A scholar is included among the top collaborators of Gamal Akabani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamal Akabani. Gamal Akabani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Su, Lu, Richen Li, Sarosh Khan, et al.. (2018). Chemical Design of Both a Glutathione-Sensitive Dimeric Drug Guest and a Glucose-Derived Nanocarrier Host to Achieve Enhanced Osteosarcoma Lung Metastatic Anticancer Selectivity. Journal of the American Chemical Society. 140(4). 1438–1446. 102 indexed citations

Akabani, Gamal, et al.. (2017). Rapid synthesis of 125I integrated gold nanoparticles for use in combined neoplasm imaging and targeted radionuclide therapy. Applied Radiation and Isotopes. 131. 49–57. 12 indexed citations

Wu, Guoyao, et al.. (2016). Control of seizures by ketogenic diet-induced modulation of metabolic pathways. Amino Acids. 49(1). 1–20. 46 indexed citations

Loesch, Kimberly, Gamal Akabani, Michael A. Deveau, et al.. (2015). Functional Genomics Screening Utilizing Mutant Mouse Embryonic Stem Cells Identifies Novel Radiation-Response Genes. PLoS ONE. 10(4). e0120534–e0120534. 4 indexed citations

Ford, John, et al.. (2015). Microbial influences on hormesis, oncogenesis, and therapy: A review of the literature. Environmental Research. 142. 239–256. 11 indexed citations

Madsen, Jonathan & Gamal Akabani. (2014). Low-energy cross-section calculations of single molecules by electron impact: a classical Monte Carlo transport approach with quantum mechanical description. Physics in Medicine and Biology. 59(9). 2285–2305. 4 indexed citations

Martin, Thomas M., et al.. (2014). Preliminary Production of 211At at the Texas A&M University Cyclotron Institute. Health Physics. 107(1). 1–9. 4 indexed citations

Metzler, Scott D., Sreekanth Vemulapalli, R.J. Jaszczak, Gamal Akabani, & Bennett B. Chin. (2009). Feasibility of Whole-Body Functional Mouse Imaging Using Helical Pinhole SPECT. Molecular Imaging and Biology. 12(1). 35–41. 11 indexed citations

Zalutsky, Michael R., David A. Reardon, Gamal Akabani, et al.. (2007). Clinical Experience with α-Particle–Emitting ²¹¹At: Treatment of Recurrent Brain Tumor Patients with ²¹¹At-Labeled Chimeric Antitenascin Monoclonal Antibody 81C6. Journal of Nuclear Medicine. 49(1). 30–38. 300 indexed citations

10.

Vemulapalli, Sreekanth, Scott D. Metzler, Gamal Akabani, et al.. (2007). Cell Therapy in Murine Atherosclerosis: In Vivo Imaging with High-Resolution Helical SPECT. Radiology. 242(1). 198–207. 13 indexed citations

11.

Akabani, Gamal, et al.. (2006). In vitro cytotoxicity of 211At-labeled trastuzumab in human breast cancer cell lines: effect of specific activity and HER2 receptor heterogeneity on survival fraction. Nuclear Medicine and Biology. 33(3). 333–347. 56 indexed citations

12.

Sampson, John H., Gamal Akabani, Allan H. Friedman, et al.. (2006). Comparison of intratumoral bolus injection and convection-enhanced delivery of radiolabeled antitenascin monoclonal antibodies. Neurosurgical FOCUS. 20(4). E14–E14. 47 indexed citations

13.

Metzler, Scott D., et al.. (2005). Molecular imaging of small animals with a triple-head SPECT system using pinhole collimation. IEEE Transactions on Medical Imaging. 24(7). 853–862. 49 indexed citations

14.

Carlin, Sean, Gamal Akabani, & Michael R. Zalutsky. (2003). In vitro cytotoxicity of (211)at-astatide and (131)I-iodide to glioma tumor cells expressing the sodium/iodide symporter.. PubMed. 44(11). 1827–38. 34 indexed citations

15.

Misra, Uma Kant, Gamal Akabani, & Salvatore V. Pizzo. (2002). The Role of cAMP-dependent Signaling in Receptor-recognized Forms of α2-Macroglobulin-induced Cellular Proliferation. Journal of Biological Chemistry. 277(39). 36509–36520. 17 indexed citations

16.

Akabani, Gamal, Ilkcan Cokgor, Robert E. Coleman, et al.. (2000). Dosimetry and dose–response relationships in newly diagnosed patients with malignant gliomas treated with Iodine-131-Labeled anti-tenascin monoclonal antibody 81C6 therapy. International Journal of Radiation Oncology*Biology*Physics. 46(4). 947–958. 52 indexed citations

17.

Morse, Michael A., et al.. (1999). Migration of human dendritic cells after injection in patients with metastatic malignancies.. PubMed. 59(1). 56–8. 298 indexed citations

18.

Larsen, Roy H., et al.. (1999). 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.. PubMed. 40(7). 1197–203. 50 indexed citations

19.

Akabani, Gamal, Craig J. Reist, Ilkcan Cokgor, et al.. (1999). Dosimetry of 131I-labeled 81C6 monoclonal antibody administered into surgically created resection cavities in patients with malignant brain tumors.. PubMed. 40(4). 631–8. 39 indexed citations

20.

Bigner, Darell D., Mark T. Brown, Allan H. Friedman, et al.. (1998). Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: phase I trial results.. Journal of Clinical Oncology. 16(6). 2202–2212. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact